Myriad Genetics Inc (NASDAQ: MYGN) stock enjoyed a major increase of 11.9% on 2/13/25. The shares closed at $14.65. Moreover, unusually high trading volume at 169% of normal accompanied the advance. The stock has been extremely weak relative to the market over the last nine months but has risen 13.3% during the last week.
Current PriceTarget Research Rating
Myriad Genetics has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Myriad Genetics has a poor Appreciation Score of 28 and a very low Power Rating of 10, triggering the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment